Trial · NCT00860262
Outcomes35
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 20 of 35
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change From Baseline in Trough Seated Systolic Blood Pressure (SBP) at Week 8 | baseline and week 8 | Full analysis set (FAS) included all randomised patients who had at least one seated trough cuff SBP following administration of study drug. | mmHg (millimeters of mercury) | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Trough Seated Systolic Blood Pressure at Week 6 | baseline and week 6 | Full analysis set (FAS) included all patients who had efficacy data consisting of a baseline and at least one post-baseline trough BP measurement. | mmHg (millimeters of mercury) | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Trough Seated Systolic Blood Pressure at Week 4 | baseline and week 4 | Full analysis set (FAS) included all patients who had efficacy data consisting of a baseline and at least one post-baseline trough BP measurement. | mmHg (millimeters of mercury) | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Trough Seated Systolic Blood Pressure at Week 2 | baseline and week 2 | Full analysis set (FAS) included all patients who had efficacy data consisting of a baseline and at least one post-baseline trough BP measurement. | mmHg (millimeters of mercury) | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Trough Seated Systolic Blood Pressure at Week 1 | baseline and week 1 | Full analysis set (FAS) included all patients who had efficacy data consisting of a baseline and at least one post-baseline trough BP measurement. | mmHg (millimeters of mercury) | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Trough Seated Diastolic Blood Pressure (DBP) at Week 8 | baseline and week 8 | Full analysis set (FAS) included all patients who had efficacy data consisting of a baseline and at least one post-baseline trough BP measurement. | mmHg (millimeters of mercury) | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Trough Seated Diastolic Blood Pressure at Week 6 | baseline and week 6 | Full analysis set (FAS) included all patients who had efficacy data consisting of a baseline and at least one post-baseline trough BP measurement. | mmHg (millimeters of mercury) | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Trough Seated Diastolic Blood Pressure at Week 4 | baseline and week 4 | Full analysis set (FAS) included all patients who had efficacy data consisting of a baseline and at least one post-baseline trough BP measurement. | mmHg (millimeters of mercury) | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Trough Seated Diastolic Blood Pressure at Week 2 | baseline and week 2 | Full analysis set (FAS) included all patients who had efficacy data consisting of a baseline and at least one post-baseline trough BP measurement. | mmHg (millimeters of mercury) | LEAST_SQUARES_MEAN |
| SECONDARY | Change From Baseline in Trough Seated Diastolic Blood Pressure at Week 1 | baseline and week 1 | Full analysis set (FAS) included all patients who had efficacy data consisting of a baseline and at least one post-baseline trough BP measurement. | mmHg (millimeters of mercury) | LEAST_SQUARES_MEAN |
| SECONDARY | Patients Achieving Diastolic Blood Pressure Control at Week 1 | week 1 | Full analysis set, imputation method used was last observation carried forward (LOCF). | participants | NUMBER |
| SECONDARY | Patients Achieving Diastolic Blood Pressure Control at Week 2 | week 2 | FAS (LOCF) | participants | NUMBER |
| SECONDARY | Patients Achieving Blood Pressure Control at Week 1 | week 1 | FAS (LOCF) | participants | NUMBER |
| SECONDARY | Patients Achieving Blood Pressure Control at Week 2 | week 2 | FAS (LOCF) | participants | NUMBER |
| SECONDARY | Patients Achieving Diastolic Blood Pressure Response at Week 1 | baseline, week 1 | FAS (LOCF) | participants | NUMBER |
| SECONDARY | Patients Achieving Diastolic Blood Pressure Response at Week 2 | baseline, week 2 | FAS (LOCF) | participants | NUMBER |
| SECONDARY | Patients Achieving Systolic Blood Pressure Response at Week 1 | baseline, week 1 | FAS (LOCF) | participants | NUMBER |
| SECONDARY | Patients Achieving Systolic Blood Pressure Response at Week 2 | baseline, week 2 | FAS (LOCF) | participants | NUMBER |
| SECONDARY | Number of Patients Achieving Various Blood Pressure Response Levels at Week 1 | week 1 | FAS (LOCF) | participants | NUMBER |
| SECONDARY | Number of Patients Achieving Various Blood Pressure Response Levels at Week 2 | week 2 | FAS (LOCF) | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00860262/outcomes